Phase I trial of tasquinimod in patients with castration-resistant prostate cancer.
Phase of Trial: Phase I
Latest Information Update: 18 May 2010
At a glance
- Drugs Tasquinimod (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 18 May 2010 Status changed from active, no longer recruiting to completed.
- 14 Mar 2007 New trial record.